Feng‐Juan Han

831 total citations
45 papers, 550 citations indexed

About

Feng‐Juan Han is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Feng‐Juan Han has authored 45 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Reproductive Medicine and 9 papers in Cancer Research. Recurrent topics in Feng‐Juan Han's work include Cancer Mechanisms and Therapy (7 papers), Ovarian function and disorders (6 papers) and Endometriosis Research and Treatment (5 papers). Feng‐Juan Han is often cited by papers focused on Cancer Mechanisms and Therapy (7 papers), Ovarian function and disorders (6 papers) and Endometriosis Research and Treatment (5 papers). Feng‐Juan Han collaborates with scholars based in China, United States and Hong Kong. Feng‐Juan Han's co-authors include Fang-Yuan Liu, Xiaoke Wu, Liangzhen Xie, Lihui Hou, Yuehui Zhang, Taixiang Wu, Yan Li, Ernest Hung Yu Ng, Ying Shen and Elisabet Stener‐Victorin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Frontiers in Immunology.

In The Last Decade

Feng‐Juan Han

39 papers receiving 540 citations

Peers

Feng‐Juan Han

PHEOH

PHARM

Samira Asghari Iran

Yi‐Fen Chiang Taiwan

Roohi Jeelani United States

K.S. Oh South Korea

Nooshin Shabab Iran

Pooja Popli India

Minghui Chen China

Habiba Sultana Bangladesh

Verda J. Hunter United States

Lei Dou China

Samira Asghari Iran

Feng‐Juan Han

79 ×0.3

289 ×1.5

37 ×0.3

PHEOH

110 ×1.5

25 ×0.4

PHARM

Citations per year, relative to Feng‐Juan Han Feng‐Juan Han (= 1×) peers Samira Asghari

Countries citing papers authored by Feng‐Juan Han

Since Specialization

Citations

This map shows the geographic impact of Feng‐Juan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Juan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Juan Han more than expected).

Fields of papers citing papers by Feng‐Juan Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Juan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Juan Han. The network helps show where Feng‐Juan Han may publish in the future.

Co-authorship network of co-authors of Feng‐Juan Han

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Juan Han. A scholar is included among the top collaborators of Feng‐Juan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Juan Han. Feng‐Juan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Mengya, et al.. (2025). Research Progress of Traditional Chinese Medicine Monomer Inhibiting Metastatic Colonization of Ovarian Cancer Cells Based on Cell Biology. Integrative Cancer Therapies. 24. 1583660089–1583660089. 1 indexed citations

Zhu, Yufei, et al.. (2025). Unveiling the Therapeutic Potential of Trigonelline: A Promising Approach in Cancer Prevention and Treatment. Anti-Cancer Agents in Medicinal Chemistry. 25(16). 1175–1187.

Wang, Siyu, Chan Li, Yuting Ma, et al.. (2025). Stem cell theory: A new horizon for the treatment of endometriosis by targeting mesenchymal stem cell. International Journal of Gynecology & Obstetrics. 170(2). 588–600.

Zhang, Ailin, John Huang, Yutong Liu, et al.. (2024). Hyaluronic acid application strategies for plant bioactive component delivery: A review. International Journal of Biological Macromolecules. 282(Pt 3). 137129–137129. 4 indexed citations

Li, Jia, et al.. (2024). Endoplasmic reticulum stress response pathway-mediated cell death in ovarian cancer. Frontiers in Oncology. 14. 1446552–1446552. 3 indexed citations

Yu, Yang, et al.. (2024). Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer. Genes & Genomics. 46(6). 689–699. 3 indexed citations

Peng, Cheng, Yu Wang, Ying Guo, et al.. (2024). A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine. Journal of Ethnopharmacology. 334. 118491–118491. 5 indexed citations

Liu, Shaoxuan, et al.. (2024). Does a high peritoneal cancer index lead to a worse prognosis of patients with advanced ovarian cancer?: a systematic review and meta-analysis based on the latest evidence. Frontiers in Oncology. 14. 1421828–1421828. 2 indexed citations

Shen, Ying, et al.. (2024). Independent organelle and organelle—organelle interactions: essential mechanisms for malignant gynecological cancer cell survival. Frontiers in Immunology. 15. 1393852–1393852. 4 indexed citations

10.

Liu, Fang-Yuan, Shaoxuan Liu, Peng Cheng, et al.. (2023). Icariin as a potential anticancer agent: a review of its biological effects on various cancers. Frontiers in Pharmacology. 14. 1216363–1216363. 16 indexed citations

11.

Li, Chan, et al.. (2023). Research progress on the mechanism of glycolysis in ovarian cancer. Frontiers in Immunology. 14. 1284853–1284853. 21 indexed citations

12.

Han, Feng‐Juan, et al.. (2022). Current Research on Complementary and Alternative Medicine in the Treatment of Premature Ovarian Failure: An Update Review. Evidence-based Complementary and Alternative Medicine. 2022. 1–18. 12 indexed citations

13.

Liu, Fang-Yuan, et al.. (2022). Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta‐Analysis and Trial Sequential Analysis. BioMed Research International. 2022(1). 3915402–3915402. 3 indexed citations

14.

Shen, Ying, et al.. (2022). Complementary and Alternative Medicine for Premature Ovarian Insufficiency: A Review of Utilization and Mechanisms. Evidence-based Complementary and Alternative Medicine. 2022. 1–15. 14 indexed citations

15.

Liu, Fang-Yuan, et al.. (2021). The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 27 indexed citations

16.

Xu, Jiayue, Fang-Yuan Liu, Shaoxuan Liu, et al.. (2021). Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/β-Catenin Signaling Pathway: Review of Mechanisms and Prospects. Journal of Oncology. 2021. 1–10. 11 indexed citations

17.

Xie, Liangzhen, et al.. (2021). Insights into the Role of Oxidative Stress in Ovarian Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 8388258–8388258. 41 indexed citations

18.

Zhang, Yuehui, et al.. (2014). The Effect of Complementary and Alternative Medicine on Subfertile Women with In Vitro Fertilization. Evidence-based Complementary and Alternative Medicine. 2014(1). 419425–419425. 10 indexed citations

19.

Zhang, Yuehui, et al.. (2014). The Complementary and Alternative Medicine for Endometriosis: A Review of Utilization and Mechanism. Evidence-based Complementary and Alternative Medicine. 2014(1). 146383–146383. 54 indexed citations

20.

Zhang, Yuehui, et al.. (2014). Applications and Therapeutic Actions of Complementary and Alternative Medicine for Women with Genital Infection. Evidence-based Complementary and Alternative Medicine. 2014(1). 658624–658624. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact